Upon completion of the activity, participants should be able to:

• Recognize the effect of brain cholesterol turnover on neurologic health
• Evaluate the impact of dysregulated cholesterol in the brain and implications for developmental and epileptic encephalopathies (DEEs)
• Assess ongoing developments in clinical research related to the management of DEEs

This symposium is intended for adult and pediatric epileptologists, adult and pediatric neurologists, and other interested members of the healthcare team.

This activity is provided by The France Foundation.

In support of improving patient care, this activity has been planned and implemented by The France Foundation. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians: The France Foundation designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: The France Foundation designates this activity for 2.5 nursing contact hours.

Physician Assistants: The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.5 AAPA Category 1 CME credits.

PAs should only claim credit commensurate with the extent of their participation.

This activity is supported by an independent educational grant from Takeda Pharmaceuticals.